CF
BPMC

CNA Financial’s Blueprint Medicines BPMC Stock Holding History

CNA Financial’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,699
Closed -$441K – 89
2022
Q3 		$441K Sell
6,699
-1,110
-14% -$71.3K 0.17% 126
2022
Q2 		$394K Buy
7,809
+40
+0.5% +$2.34K 0.14% 146
2022
Q1 		$496K Sell
7,769
-70
-0.9% -$5.03K 0.15% 148
2021
Q4 		$840K Buy
7,839
+70
+0.9% +$7.32K 0.22% 123
2021
Q3 		$799K Sell
7,769
-190
-2% -$17.7K 0.22% 131
2021
Q2 		$700K Sell
7,959
-480
-6% -$44K 0.2% 142
2021
Q1 		$821K Buy
8,439
+640
+8% +$63.9K 0.25% 121
2020
Q4 		$875K Buy
7,799
+40
+0.5% +$4.21K 0.27% 107
2020
Q3 		$719K Buy
7,759
+999
+15% +$76.9K 0.26% 99
2020
Q2 		$527K Buy
+6,760
New +$457K 0.21% 115

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

CNA Financial's BPMC Position: Q4 2022 in Review

CNA Financial sold out of Blueprint Medicines (BPMC) in Q4 2022, closing a stake of 6,699 shares — an estimated $441K sold.

CNA Financial first reported a position in BPMC in Q2 2020 and held it in 10 quarters. The position peaked at $875K in Q4 2020. 223 funds tracked by Wall St. Rank hold BPMC as of Q4 2022.

  • CNA Financial reported no remaining Blueprint Medicines position as of Q4 2022 after selling out during the quarter.
  • CNA Financial sold 6,699 Blueprint Medicines shares in Q4 2022, an estimated $441K.
  • CNA Financial first reported a position in Blueprint Medicines in Q2 2020 and held it in 10 quarters.
  • CNA Financial's Blueprint Medicines position peaked at $875K in Q4 2020.
  • 223 funds tracked by Wall St. Rank held Blueprint Medicines as of Q4 2022.

Based on CNA Financial's 13F filing for Q4 2022, filed 10 Feb 2023.